Table 4. Meta-analyses reporting cardiovascular symptoms in patients with COVID-19

First author (date of publication)	Study period	Number of studies/participants	Prevalence of symptoms (95% CI)
Groff (Oct 13, 2021)	Dec 2019 to Mar 2021	57/250,351	Chest pain 13.3% (IQR, 8.8% to 17.8%)Palpitation 9.3% (IQR, 6.0% to 10.8%)
Mirmoeeni (Apr 24, 2021)	Dec 2019 to Apr 2020	16/4,754	Chest pain 7.80% (2.74% to 12.86%)Arrhythmias 1.92% (0.35% to 3.50%)

CI, confidence interval; COVID-19, coronavirus disease 2019; IQR, Interquartile range.